BMS-986345

BMS-986345 · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986345, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]